http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109771529-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e104d9c32c6efb21ef851b32a7550d03 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2017-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_348041a20d4114d7de54fef5c4ca3d4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_799cd8836e8c14dd387b54c9707db0dc |
| publicationDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109771529-A |
| titleOfInvention | Pharmaceutical composition, its extract, preparation method and application for treating brain tumor |
| abstract | The invention discloses a kind of pharmaceutical compositions for treating brain tumor, its extract, preparation method and application.The pharmaceutical composition includes: 20-40 parts of ganoderma lucidum polysaccharide, 5-25 parts of astragalus polyose, 5-25 parts of polysaccharides from ginkgo biloba, 10-30 parts of Chinese ephedra, 4-24 parts of ramulus cinnamomi, 8-28 parts of blackberry lily, 2-18 parts of Lasiosphaera fenzlii, 1-5 parts of borneol, 1-5 parts of saussurea involucrata, 10-40 parts of rhizoma acori graminei and 5-20 parts of safflower.It also can further include western medicine component in the pharmaceutical composition: Verapamil, tamoxifen and melatonin.For pharmaceutical composition of the invention in the treatment to patient with brain tumors, recurrence rate is low, and side effect is low, and therapeutic effect is good, and wherein one annual survival rate of patient with brain tumors is improved to 80% or so, three annual survival rate by 28% or so and improved by 17% or so to 45% or so. |
| priorityDate | 2017-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.